HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use COTELLIC safely and effectively. See full prescribing information for COTELLIC. COTELLIC (cobimetinib) tablets, for

Source URL: www.accessdata.fda.gov

• Chemistry
• Clinical medicine
• Organic chemistry
• MEK inhibitor
• Protein kinase inhibitors
• B-Raf inhibitor
• Sulfonamides
• Vemurafenib
• Cobimetinib
• Keratoacanthoma
• Ofloxacin

SPECIAL AUTHORIZATION REQUEST FOR COVERAGE OF HIGH COST CANCER DRUGS (Vemurafenib, Abiraterone, Enzalutamide) Part 1 - Patient Information

Source URL: www.gov.pe.ca

• Prostate cancer
• Abiraterone
• Melanoma
• Docetaxel
• Vemurafenib
• Metastasis
• Eastern Cooperative Oncology Group
• Medicine
• Chemistry
• Organofluorides

Machine Reading for Cancer Panomics Hoifung Poon 1

Source URL: www.akbc.ws

• Sulfonamides
• Vemurafenib
• Medicine
• Chemistry
• BRAF
• Biology
• Melanoma
• Organochlorides
• Organofluorides

490 NEDERLANDS TIJDSCHRIFT VOOR DERMATOLOGIE EN VENEREOLOGIE | VOLUME 23 | NUMMER 08 | september 2013 Spiny folliculaire hyperkeratose door vemurafenib, een BRAF‑remmer

Source URL: www.nvdv.nl

Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent

Source URL: www.translational-medicine.com

Opportunity Combination of mutant BRAF inhibitor with Pyruvate Dehydrogenase Kinase isoform 1 (PDK-1) inhibitor for treatment of melanoma/ overcoming BRAF inhibitor resistance •

Source URL: www.amsterdameconomicboard.com

• Melanoma
• Vemurafenib
• BRAF
• PDK1
• Pyruvate dehydrogenase kinase
• Mammalian target of rapamycin
• Targeted therapy
• Biology
• Medicine
• Chemistry

Combinatorial Testing of an ERK Inhibitor, SCHwith PI3K/AKT/mTOR Inhibitors in Melanoma Master Thesis In order to obtain the academic degree

Source URL: www.marshallplan.at

• Cell biology
• Biochemistry
• Oncogenes
• C-Raf
• Vemurafenib
• BRAF
• PI3K/AKT/mTOR pathway
• Raf kinase
• AKT
• Biology
• Signal transduction
• Protein kinases

SMC briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medici

Source URL: www.scottishmedicines.org.uk

• Anatomy
• Aging-associated diseases
• Autoimmune diseases
• Tocilizumab
• Multiple sclerosis
• Scottish Medicines Consortium
• Rheumatoid arthritis
• Fingolimod
• Vemurafenib
• Health
• Medicine
• Immunosuppressants

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

Source URL: www.translational-medicine.com

• Tumor suppressor genes
• Carcinogenesis
• Melanoma
• Vemurafenib
• BRAF
• Selumetinib
• Phosphoinositide 3-kinase
• COSMIC cancer database
• AKT
• Medicine
• Oncology
• Oncogenes

Professor Richard Kefford AM T: +F: +E: - 2000 -

Source URL: wmi.org.au

• Melanoma
• Vemurafenib
• Chemistry